H. Tawfik-Schlieper, K. Klotz, V. Kreye, and U. Schwabe. Naunyn Schmiedebergs Arch Pharmacol, 340 (6):
684-8(December 1989)Tawfik-Schlieper, H Klotz, K N Kreye, V A Schwabe, U In Vitro Research
Support, Non-U.S. Gov't Germany, west Naunyn-Schmiedeberg's archives
of pharmacology Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):684-8..
K. Klotz, H. Vogt, and H. Tawfik-Schlieper. Naunyn Schmiedebergs Arch Pharmacol, 343 (2):
196-201(February 1991)Klotz, K N Vogt, H Tawfik-Schlieper, H Comparative Study Germany
Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs
Arch Pharmacol. 1991 Feb;343(2):196-201..
A. Wilken, H. Tawfik-Schlieper, K. Klotz, and U. Schwabe. Mol Pharmacol, 37 (6):
916-20(June 1990)Wilken, A Tawfik-Schlieper, H Klotz, K N Schwabe, U Research Support,
Non-U.S. Gov't United states Molecular pharmacology Mol Pharmacol.
1990 Jun;37(6):916-20..
D. Ukena, C. Schirren, K. Klotz, and U. Schwabe. Naunyn Schmiedebergs Arch Pharmacol, 331 (1):
89-95(October 1985)Ukena, D Schirren, C G Klotz, K N Schwabe, U In Vitro Germany, west
Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs
Arch Pharmacol. 1985 Oct;331(1):89-95..